✦ LIBER ✦

Prognostic variables for ovarian cancer

✍ Scribed by M. Rosman; C.L. Hayden; P.E. Schwartz; S.K. Chambers; J.T. Chambers; E.I. Kohorn

Book ID: 119054343
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 152 KB
Volume: 45
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(92)90616-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early serum negativity of CA-125 is a pr

Early serum negativity of CA-125 is a prognostic variable in patients treated for epithelial ovarian cancer

✍ P.R. Dottino; R.A. Segna; C.J. Cohen 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Serum Half-Life of CA 125 during Early C

Serum Half-Life of CA 125 during Early Chemotherapy as an Independent Prognostic Variable for Patients with Advanced Epithelial Ovarian Cancer: Results of a Multicentric Italian Study

✍ Angiolo Gadducci; Paolo Zola; Fabio Landoni; Tiziano Maggino; Enrico Sartori; Ti 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Prognostic value of clinical variables i

Prognostic value of clinical variables in ovarian cancer

✍ Paul DiSilvestro; Jeffrey F. Peipert; Joseph W. Hogan; Cornelius O. Granai 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 448 KB

Prognostic variables of women with ovari

Prognostic variables of women with ovarian cancer undergoing second look procedures

✍ L.C. Fuith; G. Reibnegger; D. Fuchs; H. Wachter 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 155 KB

Serum and tissue biomarkers as predictiv

Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer

✍ Angiolo Gadducci; Stefania Cosio; Roberta Tana; Andrea Riccardo Genazzani 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Prognostic evaluation of lymphadenectomy

Prognostic evaluation of lymphadenectomy for epithelial ovarian cancer

✍ Fumitaka Kikkawa; Hisatake Ishikawa; Koji Tamakoshi; Nobuhiko Sucanuma; Kimio Mi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB

## Abstract Between 1989 and 1991, 150 patients with ovarian cancer were treated with chemotherapy, including cisplatin, in the Tokai Ovarian Tumor Study Group. Of these patients, 25 underwent cytoreductive surgery with lymphadenectomy, including removal of either pelvic or para‐aortic lymph nodes,